Cassava Sciences | PTIE - Ebit





Ebit Veränderung Datum
Abbott USD 2.13B 281M 2026-06
Amgen USD 4.61B 777M 2026-06
Biogen USD -243.8M 758.1M 2026-06
Cara Therapeutics USD -7.05M 1.11M 2026-03
Cassava Sciences USD -11.17M 2.38M 2026-03
Eisai JPY 24.73B 35.04B 2026-06
Eli Lilly USD 12.46B 2.68B 2026-06
Geron USD -236K 10.55M 2026-03
J&J USD 6.47B 1B 2026-09
Merck USD 840M 2.72B 2026-06
Novartis USD 4.73B 549M 2026-06
Novavax USD 20.94M 100.32M 2025-12
Pfizer USD -180M 5.16B 2026-06
Roche Holding CHF 11.46B 1.91B 2026-06